Skip to content
OpenCapital
Get started

Cardinal Health CAH Pharmaceutical and Specialty Solutions — Total operating earnings

Other segment segments

Other Segments
$179M+33.6%
Cost of product sold
$25M-35.9%

Similar metrics at other companies

Baxter International logo
BAXPharmaceuticals — Segment operating income
$46M-27.0%
Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Operating Income (Loss)
$50.06M+234%
Novanta logo
NOVTMedical Solutions — Segment Operating Income
$16.73M+19.2%
Scansource logo
SCSCSpecialty Technology Solutions — Operating Income (Loss)
$15.13M+5.9%
UCT
UCTTSemiconductor Products And Solutions — Total segment operating profit
$7M-30.7%
BrightSpring Health Services, Inc. logo
BTSGPharmacy Solutions — Earnings Before Interest Income Taxes Depreciation And Amortization From Reportable
$169.07M+46.1%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$54.98B+41.0%
Enterprise value$59.96B+38.3%
P/E35.4×+10.3×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%—
Debt / equity4.1×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's pharmaceutical and specialty solutions — total operating earnings.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's pharmaceutical and specialty solutions — total operating earnings?
Cardinal Health (CAH) reported pharmaceutical and specialty solutions — total operating earnings of $784M in Q1 2026.
How has Cardinal Health's pharmaceutical and specialty solutions — total operating earnings changed year-over-year?
Cardinal Health's pharmaceutical and specialty solutions — total operating earnings increased by 18.4% year-over-year, from $662M to $784M.
What is the long-term trend for Cardinal Health's pharmaceutical and specialty solutions — total operating earnings?
Over 2 years (2022 to 2025), Cardinal Health's pharmaceutical and specialty solutions — total operating earnings has grown at a 17.2% compound annual growth rate (CAGR), from $1.64B to $2.26B.
What does pharmaceutical and specialty solutions — total operating earnings mean?
The profit generated by the Pharmaceutical and Specialty Solutions segment after deducting all operating costs and expenses from segment revenue. This is the key measure of the segment's core profitability and operational performance. It excludes interest, taxes, and corporate-level allocations to isolate the segment's specific contribution to the company.